• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Reversible inhibition of cytomegalovirus replication by phosphonoformate.

作者信息

Wahren B, Oberg B

出版信息

Intervirology. 1980;14(1):7-15. doi: 10.1159/000149156.

DOI:10.1159/000149156
PMID:6259084
Abstract

Cytomegalovirus (CMV Ad. 169)-induced late antigens are specifically inhibited by phosphonoformate (PFA). Four fresh isolates of CMV were also inhibited by PFA to varying degrees. The kinetics of CMV immediate early antigens (IEA) and early nuclear antigens (EA) produced in the presence of PFA were compared to the early phase of the replicative infection. After anticomplement immunofluorescence with anti-IEA and anti-EA, microimmunofluorometry of individual CMV-infected nuclei was performed. CMV-induced antigens had a two-wave appearance, with maxima at 6 and 24 h postinfection. The same was seen in the presence of PFA. CMV EA-containing cells persisted for more than 5 weeks in the presence of PFA, but decreased in frequency and antigen content. The inhibition of virus replication was reversible after all incubation periods assayed. After PFA release, IEA and EA appeared again in many cells, and the kinetics were similar to that of initial infection. The results suggest that the input CMV genome persists in most initially infected cells, survives PFA incubation, and is active again after PFA release. This differs from abortive CMV infections.

摘要

相似文献

1
Reversible inhibition of cytomegalovirus replication by phosphonoformate.
Intervirology. 1980;14(1):7-15. doi: 10.1159/000149156.
2
Inhibition of cytomegalovirus late antigens by phosphonoformate.
Intervirology. 1980;12(6):335-9. doi: 10.1159/000149093.
3
Activity of the cytomegalovirus genome in the presence of PPi analogs.巨细胞病毒基因组在焦磷酸类似物存在下的活性。
J Virol. 1985 Dec;56(3):996-1001. doi: 10.1128/JVI.56.3.996-1001.1985.
4
Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro.3'-叠氮-3'-脱氧胸苷(齐多夫定)与膦甲酸盐(膦甲酸)联合用于抗1型人类免疫缺陷病毒及体外巨细胞病毒复制的研究
Antimicrob Agents Chemother. 1989 May;33(5):663-9. doi: 10.1128/AAC.33.5.663.
5
Antiviral effects of phosphonoformate (PFA, foscarnet sodium).膦甲酸(PFA,膦甲酸钠)的抗病毒作用。
Pharmacol Ther. 1982;19(3):387-415. doi: 10.1016/0163-7258(82)90074-2.
6
Induction of Epstein-Barr virus antigens and DNA-polymerase activities in P3HR-1 cell line and its subline passaged in the presence of phosphonoformate.在膦甲酸存在的情况下传代的P3HR-1细胞系及其亚系中爱泼斯坦-巴尔病毒抗原和DNA聚合酶活性的诱导。
Acta Virol. 1983 Jul;27(4):329-36.
7
Enrichment of early HSV-induced proteins in phosphonoformate-treated cells.
Acta Virol. 1984 Jan;28(1):11-8.
8
Conditions for cytomegalovirus stimulation of lymphocytes.
Scand J Immunol. 1981;13(6):581-6. doi: 10.1111/j.1365-3083.1981.tb00172.x.
9
In vitro inhibition of human herpesvirus-6 by phosphonoformate.膦甲酸对人疱疹病毒6型的体外抑制作用
J Virol Methods. 1988 Sep;21(1-4):301-4. doi: 10.1016/0166-0934(88)90075-4.
10
Phosphonoformate inhibits reverse transcriptase.膦甲酸抑制逆转录酶。
J Gen Virol. 1979 Nov;45(2):273-81. doi: 10.1099/0022-1317-45-2-273.

引用本文的文献

1
Foscarnet penetrates the blood-brain barrier: rationale for therapy of cytomegalovirus encephalitis.膦甲酸可穿透血脑屏障:治疗巨细胞病毒性脑炎的理论依据。
Antimicrob Agents Chemother. 1993 May;37(5):1010-4. doi: 10.1128/AAC.37.5.1010.
2
Penetration of foscarnet into cerebrospinal fluid of AIDS patients.膦甲酸钠在艾滋病患者脑脊液中的渗透情况。
Antimicrob Agents Chemother. 1993 Sep;37(9):1777-80. doi: 10.1128/AAC.37.9.1777.
3
High dose intravitreal foscarnet in the treatment of cytomegalovirus retinitis in AIDS.高剂量玻璃体内膦甲酸钠治疗艾滋病患者的巨细胞病毒性视网膜炎
Br J Ophthalmol. 1994 Feb;78(2):120-4. doi: 10.1136/bjo.78.2.120.
4
Antiviral effect in human cytomegalovirus-infected cells, pharmacokinetics, and intravitreal toxicology in rabbits of acyclovir diphosphate dimyristoylglycerol.二磷酸阿昔洛韦二肉豆蔻酰甘油在人巨细胞病毒感染细胞中的抗病毒作用、药代动力学及兔玻璃体内毒理学研究
Antimicrob Agents Chemother. 1995 Jun;39(6):1383-5. doi: 10.1128/AAC.39.6.1383.
5
Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections.膦甲酸钠。对其在免疫功能低下的病毒感染患者中的抗病毒活性、药代动力学特性及治疗用途的重新评估。
Drugs. 1994 Aug;48(2):199-226. doi: 10.2165/00003495-199448020-00007.
6
D,L-alpha-difluoromethylornithine inhibits human cytomegalovirus replication.D,L-α-二氟甲基鸟氨酸抑制人巨细胞病毒复制。
J Virol. 1984 Apr;50(1):145-54. doi: 10.1128/JVI.50.1.145-154.1984.
7
Early interactions between human cytomegalovirus and cells.人类巨细胞病毒与细胞之间的早期相互作用。
Arch Virol. 1984;79(1-2):55-65. doi: 10.1007/BF01314303.
8
Association between virus and cell DNA during latent cytomegalovirus infection in vitro.体外巨细胞病毒潜伏感染期间病毒与细胞DNA之间的关联。
Arch Virol. 1983;75(4):291-8. doi: 10.1007/BF01314895.
9
Inhibitory effects of foscarnet on herpesvirus multiplication in cell culture.膦甲酸钠对细胞培养中疱疹病毒增殖的抑制作用。
Arch Virol. 1981;68(3-4):203-9. doi: 10.1007/BF01314573.
10
Management of infectious and immunological complications of acquired immunodeficiency syndrome (AIDS). Current and future prospects.
Drugs. 1987 Jan;33(1):66-84. doi: 10.2165/00003495-198733010-00004.